fda removes semaglutide from drug shortage list february 21 2025 Novo's Wegovy and Ozempic removed US list, compounders on notice Semaglutide shortage ends as FDA

Comments were received regarding specific services assigned to New Technology APCs with low claims volume that supported maintaining the APC assignment as a result of our proposal to continue to exempt services assigned to New Technology APCs with fewer than 10 claims over the 4-year lookback period from the universal low volume policy

These are signs that there is too much sugar in your blood and your treatment may need adjusting

Semaglutide is a GLP-1 medication class that can reduce appetite and support weight loss for qualified patients under medical supervision

Would you be willing to write a letter of medical necessity for my appeal